Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.12%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.00%
#5 RedStone RedStone +28.08%
#6 Humanity Humanity +25.92%
#7 Codatta Codatta +22.12%
#8 Walrus Walrus +20.05%
#9 Enso Enso +18.97%
#10 Tutorial Tutorial +17.31%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rang în acțiuni #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Preț acțiune
$0.117
Ultima sincronizare: 2025-04-04
Capitalizare de piață
$2.45M
Schimbare (1 zi)
-13.59%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Carmell Therapeutics Corporation (CTCX)

Categorie

Healthcare
Raport P/S pentru Carmell Therapeutics Corporation (CTCX)
Raport P/S la data de August 2026 TTM: 3.52
Conform celor mai recente rapoarte financiare și prețului acțiunilor Carmell Therapeutics Corporation, raportul P/S actual (TTM) este 3.52. La sfârșitul anului 2023, compania avea un P/S de 0.00.
Istoricul raportului P/S pentru Carmell Therapeutics Corporation din 2021 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 3.52 -99.90%
2024 3.48K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 188.58%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 187.49%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 34.60%
BE